---
schema_version: "secwatch.filing_event.v1"
accession: "0001824293-24-000023"
form_type: "8-K"
ticker: "GRI"
cik: "0001824293"
company_name: "GRI Bio, Inc."
filed_at: "2024-01-30T23:59:59+00:00"
generated_at: "2026-06-06T15:09:21.505435+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# GRI Bio implements 1-for-7 reverse stock split to regain Nasdaq compliance

## Summary
- Effective 4:01 p.m. ET Jan 29, 2024; post-split trading begins Jan 30 under symbol GRI.
- Outstanding shares reduced from ~4,520,233 to ~645,736; authorized shares unchanged.
- Proportional adjustments to per-share exercise price and shares issuable under outstanding options, warrants, and convertible securities.
- No fractional shares issued; stockholders receive cash in lieu based on Jan 29 closing price.
- Stockholder-approved at Jan 19 special meeting; intended to regain Nasdaq minimum bid price compliance.

## SEC filing metadata
- accession: 0001824293-24-000023
- form_type: 8-K
- ticker: GRI
- cik: 0001824293
- company_name: GRI Bio, Inc.
- filed_at: 2024-01-30T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 3.03, 5.03, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1824293/000182429324000023/0001824293-24-000023-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1824293/000182429324000023/val-20240129.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001824293-24-000023
- JSON: https://secwatch.observer/filing/0001824293-24-000023.json
- Plain text: https://secwatch.observer/filing/0001824293-24-000023.txt

## Key facts
- Governance Changes
  GRI Bio, Inc.: Amended certificate of incorporation to effect a 1-for-7 reverse stock split (effective 2024-01-29).
  - Change: charter amendment
  - Effective: 2024-01-29
  source text: On January 29, 2024, GRI Bio, Inc. (the “Company”) filed with the Secretary of State of the State of Delaware an amendment (the “Certificate of Amendment”) to its amended and restated certificate of incorporation to effect a reverse stock split of the Company's common stock, par value $0.0001 per share (the “Common Stock”), at a ratio of 1-for-7 (the “Reverse Stock Split”).
  evidence_url: https://www.sec.gov/Archives/edgar/data/1824293/000182429324000023/0001824293-24-000023-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.